Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Kwality Pharmaceuticals: Board Meeting Intimation for Consider And Approve The Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2024.
News Announcement

Kwality Pharmaceuticals: Board Meeting Intimation for Consider And Approve The Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2024.

22-Oct-2024 Follow Value Research Online on Google download pdfDownload PDF Kwality Pharma

Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2024 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results for the Quarter and Half year ended September 30 2024.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.